FDA Inspection 1177408 — Peptido, chemische und pharmazeutische Rohstoffgesellschaft mit beschrankter Haftung
The FDA completed an inspection of Peptido, chemische und pharmazeutische Rohstoffgesellschaft mit beschrankter Haftung on March 11, 2022 in Bexbach. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 11, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bexbach (Germany)
Additional Details
Mutual Recognition Agreement (MRA)